NEXT

National Law Journal

Why Sanofi-Aventis Wants to Postpone the 1st Taxotere Bellwether Trial

In a motion to continue the Sept. 16 trial, Sanofi-Aventis cited the U.S. Supreme Court's Merck v. Albrecht decision, which prompted another federal judge to postpone the first bellwether trial over anti-nausea medication Zofran.
6 minute read

Daily Report Online

Law Firms See Promise—and Peril—in Multibillion-Dollar Vaping Market

The booming vape and e-cigarette industry could mean big legal business—or it could go up in smoke.
10 minute read

New York Law Journal

Marketing of CBD Products

For the businesses that wish to push forward on this uncertain landscape, cautious and strategic marketing may be the best—although not risk free—course of action.
11 minute read

Corporate Counsel

Report: Cannabis In-House Counsel Expect to Spend More to Keep Up With Market

Many in-house counsel, according to the report, have growing concerns over cannabis-related litigation.
4 minute read

The Recorder

Food Litigator Rejoins Jenner & Block After In-House Stint at Wonderful

Kate Spelman has returned to Jenner & Block's Los Angeles office as a partner in its complex commercial litigation practice.
3 minute read

Law.com

Higher Law: A Sidley Partner's CBD Thoughts | USDA Hemp Guidance | Arizona Court Defines Medical Marijuana

Welcome to Higher Law -- our weekly roundup of news and analysis for cannabis industry lawyers. Thanks for reading!
9 minute read

The Legal Intelligencer

Cannabis and Hemp Industry Trembles After FDA Cracks the Whip

With the FDA "locked and loaded," and billions of annual sales and "deal flow capital" hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims.
10 minute read

The Recorder

How Clients in the CBD Market Can Manage Risks

CBD risk management requires constant education and vigilance to stay abreast of an area of the law changing more rapidly than any other in recent history.
10 minute read

Daily Business Review

Client Advocacy Beyond the Courtroom Helps to Deliver Real Change

In March 2019 the U.S. Food and Drug Administration issued a statement from Commissioner Scott Gottlieb and Jeff Shuren, its director of the Center for Devices and Radiological Health, on the evaluation of materials in medical devices to address potential safety issues. It was an important step in improving medical device safety.
5 minute read

Daily Business Review

Federal Judge Rejects Motion by DOJ to Disqualify Defense Attorneys in Illegal Drug and False Marketing Case

U.S. Magistrate Judge William Matthewman denied the department's request in an order issued Monday. The department had sought to preclude Kuehne Davis Law litigators Benedict "Ben" Kuehne and Michael Davis from continuing to represent dietary supplement company Blackstone Labs and its CEO, Phillip Braun.
5 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now